Literature DB >> 7890064

Habitual abortion is accompanied by low serum levels of placental protein 14 in the luteal phase of the fertile cycle.

M Tulppala1, M Julkunen, A Tiitinen, U H Stenman, M Seppälä.   

Abstract

OBJECTIVE: To study serum levels of placental protein 14 (PP14) in relation to endometrial function in women with a history of habitual abortion.
DESIGN: Prospective study.
SETTING: Departments I and II of Obstetrics and Gynecology, University Central Hospital of Helsinki, Helsinki, Finland. PATIENTS: Fifty patients (26 primary and 24 secondary habitual aborters) and 38 controls without a history of abortion studied during a regular cycle.
RESULTS: Habitual aborters as a whole or when subgrouped into those with normal cycles (n = 40) or with a luteal phase defect (LPD; n = 10) and control women demonstrated a distinct increase in PP14 levels from late follicular to late luteal phases. In the luteal phase, serum PP14 levels were lower in the patients than in the controls (27.2 +/- 3.1 versus 48.5 +/- 10.1 micrograms/L), but the differences in PP14 levels between habitual aborters with or without LPD was not significant (16.3 +/- 4.3 versus 29.9 +/- 3.7 micrograms/L).
CONCLUSIONS: Habitual aborters exhibit lower serum PP14 levels in the late luteal phase compared with normal fertile women.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7890064     DOI: 10.1016/s0015-0282(16)57483-4

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

Review 1.  Local and systemic factors and implantation: what is the evidence?

Authors:  Chelsea Fox; Scott Morin; Jae-Wook Jeong; Richard T Scott; Bruce A Lessey
Journal:  Fertil Steril       Date:  2016-03-03       Impact factor: 7.329

2.  Chronic chorioamnionitis displays distinct alterations of the amniotic fluid proteome.

Authors:  Giovanna Oggé; Roberto Romero; Deug-Chan Lee; Francesca Gotsch; Nandor Gabor Than; Joonho Lee; Tinnakorn Chaiworapongsa; Zhong Dong; Pooja Mittal; Sonia S Hassan; Chong Jai Kim
Journal:  J Pathol       Date:  2010-12-24       Impact factor: 7.996

3.  Differential expression of serum glycodelin and insulin-like growth factor binding protein 1 in early pregnancy.

Authors:  Nataki C Douglas; Melvin H Thornton; Sahadat K Nurudeen; Maria Bucur; Rogerio A Lobo; Mark V Sauer
Journal:  Reprod Sci       Date:  2013-04-12       Impact factor: 3.060

4.  Correlation of endometrial glycodelin expression and pregnancy outcome in cases with polycystic ovary syndrome treated with clomiphene citrate plus metformin: a controlled study.

Authors:  Selda Uysal; Ahmet Zeki Isik; Serenat Eris; Seyran Yigit; Yakup Yalcin; Pelin Ozun Ozbay
Journal:  Obstet Gynecol Int       Date:  2015-02-28

Review 5.  The Roles of Glycodelin in Cancer Development and Progression.

Authors:  Juan Cui; Yanguo Liu; Xiuwen Wang
Journal:  Front Immunol       Date:  2017-11-29       Impact factor: 7.561

6.  Mediation by hormone concentrations on the associations between repeated measures of phthalate mixture exposure and timing of delivery.

Authors:  Amber L Cathey; Max T Aung; Deborah J Watkins; Zaira Y Rosario; Carmen M Vélez Vega; Akram N Alshawabkeh; José F Cordero; Bhramar Mukherjee; John D Meeker
Journal:  J Expo Sci Environ Epidemiol       Date:  2022-01-05       Impact factor: 6.371

7.  Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients.

Authors:  Christoph Scholz; Sabine Heublein; Miriam Lenhard; Klaus Friese; Doris Mayr; Udo Jeschke
Journal:  BMC Res Notes       Date:  2012-10-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.